ArticleAntibiotics (Basel, Switzerland)2022
Molecular Characterization of
Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Systematic review of multidrug-resistantFrontiers in microbiology · 2025Pooled it
- Overview of Colistin Resistance in the Middle East and North Africa (MENA) Region.Microorganisms · 2026Review
- Genomic insights into multidrug resistance in clinicalFrontiers in microbiology · 2026Article
- Isolation and Characterization of Colistin-ResistantMicroorganisms · 2025Article
- Genomic characterization of multidrug-resistantFrontiers in microbiology · 2025Article
- A Systematic Review and Comprehensive Analysis ofAntibiotics (Basel, Switzerland) · 2024Review
- First Report of Colistin-ResistantAntibiotics (Basel, Switzerland) · 2024Article
- Farm to table: colistin resistance hitchhiking through food.Archives of microbiology · 2023Review
- The genomic epidemiology of Escherichia albertii infecting humans and birds in Great Britain.Nature communications · 2023Article
- Pan-Genomics ofLife (Basel, Switzerland) · 2023Article
- Early Years of Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2022Article
- Epidemiological and genomic characteristics of globalFrontiers in microbiology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Data on the prevalence of MCR-producing
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.